Search Results - "Shinchi, Yusuke"
-
1
Accurate expression of PD‐L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry
Published in Cancer science (01-09-2019)“…The percentage of programmed death ligand 1 (PD‐L1) positivity in cancer cells, named as the tumor proportion score, is considered to be a predictive biomarker…”
Get full text
Journal Article -
2
Classification of PD‐L1 expression in various cancers and macrophages based on immunohistocytological analysis
Published in Cancer science (01-09-2022)“…Programmed death (PD)‐1/PD‐ligand 1 (PD‐L1) antibodies have shown an intense clinical effect in some patients with PD‐L1+ tumors, and their applications have…”
Get full text
Journal Article -
3
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma
Published in Cancer Immunology, Immunotherapy (01-11-2022)“…Programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) are target molecules for immunotherapy in non-small cell lung cancer. PD-L1 is expressed not only in…”
Get full text
Journal Article -
4
CD163‐positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma
Published in Pathology international (01-10-2021)“…CD163 is one of the scavenger receptors expressed on macrophages. However, several immunohistochemical studies have demonstrated that CD163 is also detected on…”
Get full text
Journal Article -
5
PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma
Published in Medical molecular morphology (01-12-2023)“…Immunotherapies that target programmed cell death protein 1 (PD-1) signals are standard therapies for advanced-stage lung cancer, and the expression of…”
Get full text
Journal Article -
6
Soluble Factors Involved in Cancer Cell–Macrophage Interaction Promote Breast Cancer Growth
Published in Anticancer research (01-09-2021)“…Background/Aim: Recent studies have indicated the clinical significance of tumor-associated macrophages (TAMs) in breast cancer; however, the detailed…”
Get full text
Journal Article -
7
IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment
Published in Medical molecular morphology (01-06-2024)“…Interleukin 32 (IL-32) is a proinflammatory cytokine secreted from several kinds of cancer cells. In the present study, we investigated the significance of…”
Get full text
Journal Article -
8
Clinical impact of TROP2 in non‐small lung cancers and its correlation with abnormal p53 nuclear accumulation
Published in Pathology international (01-05-2020)“…Tumor‐associated calcium signal transducer 2 (TROP2) is a cell‐surface glycoprotein involved in the high malignant potential of several cancers. Antibody‐drug…”
Get full text
Journal Article -
9
Synchronous Multiple Lung Adenocarcinomas: Estrogen Concentration in Peripheral Lung
Published in PloS one (15-08-2016)“…The detection rate of synchronous multiple lung adenocarcinomas (SMLA), which display multiple ground glass opacity nodules in the peripheral lung, is…”
Get full text
Journal Article -
10
Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non‐small cell lung cancer and interstitial lung disease: a propensity score matching analysis
Published in Thoracic cancer (01-10-2024)“…Background Patients with early‐stage lung cancer and interstitial lung disease have a poorer prognosis than those without interstitial lung disease. This study…”
Get full text
Journal Article -
11
NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer
Published in Diagnostics (Basel) (21-02-2024)“…In non-small cell lung cancer (NSCLC) cases, detecting potential lymph node metastases is essential to determine the indications for sublobar resection or…”
Get full text
Journal Article -
12
A Case of Pancreatic Side Effects Resulting from Sorafenib and Axitinib Treatment of Stage IV Renal Cell Carcinoma
Published in Keio journal of medicine (2015)“…Tyrosine kinase inhibitors such as sorafenib and axitinib were developed to treat malignancies, including stage IV renal cell carcinoma. Recently, we…”
Get full text
Journal Article -
13
Metastatic Renal Cell Carcinoma in Paranasal Sinus for which Periodic Drug Withdrawal Schedule of Axitinib was Effective : A Case Report
Published in Hinyokika kiyo. Acta urologica Japonica (01-09-2016)“…A 73-year-old male patient underwent a right nephrectomy for renal cell carcinoma in 2008, and interferon-alpha was initiated as adjuvant treatment. Computed…”
Get full text
Journal Article -
14
Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer
Published in Oncology letters (01-07-2017)Get full text
Journal Article -
15
The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages
Published in Cancers (12-04-2023)“…Macrophages are a representative cell type in the tumor microenvironment. Macrophages that infiltrate the cancer microenvironment are referred to as…”
Get full text
Journal Article -
16
SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma
Published in Cancers (01-09-2022)“…Osteopontin, also called secreted phosphoprotein 1 (SPP1), is a multifunctional secreted phosphorylated glycoprotein. SPP1 is also expressed in tumor cells,…”
Get full text
Journal Article -
17
-
18
Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer
Published in Oncology letters (01-07-2017)“…Partial nephrectomy is the treatment of choice for small renal cell carcinoma (RCC) from the perspective of cancer management and renal function. However, when…”
Get full text
Journal Article